MFDS
- Marketing authorisation holder: NOVO
- Status: likely_approved
🇰🇷 Rivfloza in South Korea
Rivfloza (NEDOSIRAN) regulatory status in South Korea.
Marketing authorisation
Rivfloza in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Rivfloza approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Rivfloza in South Korea?
NOVO holds the South Korean marketing authorisation.